• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis.

作者信息

Khorashad J S, De Melo V A, Fiegler H, Gerrard G, Marin D, Apperley J F, Goldman J M, Foroni L, Reid A G

出版信息

Leukemia. 2008 Sep;22(9):1806-7. doi: 10.1038/leu.2008.210. Epub 2008 Jul 31.

DOI:10.1038/leu.2008.210
PMID:18668129
Abstract
摘要

相似文献

1
Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis.
Leukemia. 2008 Sep;22(9):1806-7. doi: 10.1038/leu.2008.210. Epub 2008 Jul 31.
2
Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?形态学评估能否限制特定基因检测在排除慢性髓系白血病中的应用？
Br J Haematol. 2007 May;137(4):377. doi: 10.1111/j.1365-2141.2007.06568.x. Epub 2007 Mar 21.
3
Cytogenetics of chronic myeloid leukaemia.慢性髓性白血病的细胞遗传学
Best Pract Res Clin Haematol. 2001 Sep;14(3):553-71. doi: 10.1053/beha.2001.0154.
4
Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.慢性髓系白血病：细胞遗传学方法及其在诊断和治疗中的应用
Methods Mol Biol. 2011;730:33-61. doi: 10.1007/978-1-61779-074-4_4.
5
[Diagnosis and differential diagnosis of chronic myeloid leukemia].[慢性髓性白血病的诊断与鉴别诊断]
Vopr Onkol. 2001;47(5):544-51.
6
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL.在通过实时定量聚合酶链反应（RQ-PCR）监测BCR-ABL的伊马替尼治疗的慢性期慢性粒细胞白血病（CML）患者中，常规骨髓细胞遗传学分析的临床价值有限。
Leukemia. 2006 Apr;20(4):664-70. doi: 10.1038/sj.leu.2404139.
7
Chronic myeloid leukaemia as a model of disease evolution in human cancer.慢性髓性白血病作为人类癌症疾病演变的模型。
Nat Rev Cancer. 2007 Jun;7(6):441-53. doi: 10.1038/nrc2147.
8
Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.利用RNA干扰靶向原发性人类白血病细胞：靶向Bcr-Abl可抑制慢性粒细胞白血病细胞中髓系祖细胞的自我更新。
Br J Haematol. 2005 May;129(3):377-80. doi: 10.1111/j.1365-2141.2005.05468.x.
9
Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia.
Haematologica. 2001 Mar;86(3):318-9.
10
Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.原发性和培养的慢性髓性白血病干细胞中BCR-ABL基因的不稳定性
J Natl Cancer Inst. 2007 May 2;99(9):680-93. doi: 10.1093/jnci/djk150.

引用本文的文献

1
Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia.额外染色体畸变对慢性粒细胞白血病疾病进展的影响
Front Oncol. 2019 Mar 5;9:88. doi: 10.3389/fonc.2019.00088. eCollection 2019.
2
Chronic myeloid leukemia extramedullary blast crisis presenting as central nervous system leukemia: A case report.以中枢神经系统白血病形式表现的慢性髓性白血病髓外原始细胞危象：一例报告。
Medicine (Baltimore). 2018 Nov;97(45):e13131. doi: 10.1097/MD.0000000000013131.
3
SNP Array in Hematopoietic Neoplasms: A Review.
造血系统肿瘤中的单核苷酸多态性阵列：综述
Microarrays (Basel). 2015 Dec 22;5(1):1. doi: 10.3390/microarrays5010001.
4
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.基因组不稳定性可能源于对伊马替尼耐药的慢性髓性白血病干细胞。
Blood. 2013 May 16;121(20):4175-83. doi: 10.1182/blood-2012-11-466938. Epub 2013 Mar 29.
5
Significance Analysis of Microarrays (SAM) Offers Clues to Differences Between the Genomes of Adult Philadelphia Positive ALL and the Lymphoid Blast Transformation of CML.微阵列显著性分析（SAM）为成人费城染色体阳性急性淋巴细胞白血病基因组与慢性粒细胞白血病淋巴母细胞转化之间的差异提供了线索。
Cancer Inform. 2012;11:173-83. doi: 10.4137/CIN.S9258. Epub 2012 Sep 12.
6
Genetic mechanisms of chronic myeloid leukemia blastic transformation.慢性髓性白血病原始细胞危象的遗传机制。
Curr Hematol Malig Rep. 2012 Jun;7(2):87-93. doi: 10.1007/s11899-012-0114-5.
7
Selection of therapy: rational decisions based on molecular events.治疗选择：基于分子事件的合理决策。
Hematol Oncol Clin North Am. 2011 Oct;25(5):1009-23, vi. doi: 10.1016/j.hoc.2011.09.006.
8
Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.慢性髓性白血病 2011：成就、挑战和策略——第五届 BCR-ABL1 阳性和 BCR-ABL1 阴性骨髓增殖性肿瘤研讨会会议记录。
Am J Hematol. 2011 Sep;86(9):811-9. doi: 10.1002/ajh.22097.
9
Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia.针对 RAD51 磷酸酪氨酸-315 以防止 BCR-ABL1 白血病中的不忠实重组修复。
Blood. 2011 Jul 28;118(4):1062-8. doi: 10.1182/blood-2010-09-307256. Epub 2011 Jun 7.
10
Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate.通过使用甲磺酸伊马替尼治疗的慢性期或加速期慢性髓性白血病患者的阵列比较基因组杂交技术鉴定拷贝数改变。
Int J Hematol. 2011 Apr;93(4):465-473. doi: 10.1007/s12185-011-0796-9. Epub 2011 Mar 9.